Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ISSN Print: 2278-1668, Online: 2278-0513
ARTICLE
Year: 2023   |   Volume: 12   |   Issue: 5   |   Page: 27-30     View issue

Clinical and Histopathological Patterns of Cancer in Tabuk City

 

Khalid Alhazmi1*

1Department of Pathology, Faculty of Medicine, University of Tabuk, Tabuk, Kingdom of Saudi Arabiya.


Abstract

The incidence of cancer increased substantially in the previous decades. In addition, increasing mortality was observed. No researchers have assessed cancer prevalence in Tabuk, Saudi Arabia. The current study investigated the pattern of cancer in Tabuk City, Saudi Arabia. A retrospective hospital-based study was conducted in the Pathology Department at King Fahd Specialist Hospital from June 2023 to September 2023. All the records of patients diagnosed with malignancies between 2019 and 2020 were approached confidentially according to the Helsinki Declaration. A checklist has been used to record the age, sex, residence, and marital status. The type of cancer, behavior, extent, stage, and histopathology were recorded. Out of 354 patients (52.05±17.71, and 48% females), the majority were Saudis (79.4%), 48.3% were married, and 90.97% were from Tabuk City. The specimens were obtained from lymph nodes (18.1%), breasts, and colon (14.4% each). In this study, nearly two-thirds (61.3%) were carcinoma in situ, 18.4% showed lymph node metastasis, and 9% distant metastasis. The majority of cancer (99.4%) was malignant. The commonest histopathological finding was carcinoma (malignant and undifferentiated), followed by adenocarcinoma in 19.8% and papillary thyroid carcinoma in 10.5%. The commonest malignancies in Tabuk City were breast, colon, and thyroid, respectively. Carcinoma in situ was the most common, followed by lymph node and distant metastasis. The histopathology varied between carcinoma, adenocarcinoma, and papillary carcinoma of the thyroid. Further prospective studies investigating cancer risk factors are needed.

Keywords: Cancer, Pattern, Histopathological, Clinical, Tabuk


Introduction

According to the International Agency for Research on Cancer estimate (2020), there is 19.3 million new cancer cases and Ten million cancer death worldwide. The most prevalent cancer was breast, lung, and colon cancer, respectively.[1] However, the Kingdom of Saudi Arabia is among the countries with the lowest cancer incidence. However, an increasing rate was reported, particularly for the Tabuk Region. Plausible explanations are Ramadan fasting, food full of special recipes filled with spices, significantly lower rates of smoking and alcohol drinking, and genetic predisposition. In Arab countries, Egypt and Lebanon reported the highest incidence and all ages, while Sudan and Saudi Arabia were the lowest.[2, 3] Cancer is growing at an alarming pace in Middle Eastern countries. Long-term projections show that, by 2030, there will be a 1.8-fold increase in cancer incidence.[4] There was an upsurge in liver cancer in Saudi Arabia. Riyadh, Najran, and Tabuk were the areas most affected by liver cancer during the period from 2004 to 2014. Saudi males from Jazan and females from the Northern Region reported the lowest rate.[5] The different rates of cancer across Saudi Arabia can be partially explained by the different risk factors, including viral hepatitis infection, obesity, and diabetes.[6-9] Diet and other protective factors might protect against cancer. The results will be used as a baseline and for future preventive measures. Knowledge of the special and temporal profile of cancer in Tabuk City will help to identify possible risks and protective styles. No studies have assessed the pattern of cancer in Tabuk City. Therefore, this study aims to assess the pattern and histopathological features of cancer in Tabuk City, Saudi Arabia.

Materials and Methods

This retrospective study was conducted at the pathology department in King Fahd Specialist Hospital, Tabuk City, from June 2023 to September 2023. Tabuk is the capital of the Tabuk region (Northwest of Saudi Arabia), and the population number is 667,000, according to 2021 data.
 

 

Furthermore, King Fahd Specialist Hospital is one of the three central hospitals in Tabuk City and receives a referral from the primary healthcare centers and regional hospitals in Tabuk Region. All the records of patients who were diagnosed with cancer during the period from January 2019 to January 2021 were eligible. The study was conducted over three months, from January to April 2023. The records in the Pathology Department were well-organized and easy to access and retrieve the data. A structured checklist was used to collect demographic data. Age, sex, nationality, marital status, residence inside Tabuk, type of cancer, stage, and histopathology were recorded. In addition, the extent and behavior of malignancies were recorded.

Inclusion criteria

All adults who were diagnosed with cancer.

Exclusion criteria

Children with cancer were not included.

Ethical issues

The author strictly adheres to the Helsinki Declaration. All the information was anonymous; no private information was taken. Ethical clearance was obtained from the ethical committee of the University of Tabuk (UT-282-125-2023).

Data analysis

The data were entered into an Excel sheet and presented as percentages and mean± SD. The Statistical Package for Social Sciences (IBM, SPSS, version 20, New York).)

Results and Discussion

There were 354 patients (48% women) with malignancies; their mean age was 52.05±17.71 years, the majority were Saudis (79.4%), 48.3% were married, and 90.97% were from Tabuk City Table 1.

In the present study, the biopsy source was lymph nodes in 18.1% and breast in 14.4%. Colon in 14.1%, and thyroid in 12.1%. Lung tissue constituted 3.9%, and nasopharyngeal, stomach, and mouth biopsy represented 3.7%, 3.7%, and 3.1%, respectively. Table 2 depicts the cancer site in the study group.

In this study, nearly two-thirds (61.3%) were carcinoma in situ, 18.4% showed lymph node metastasis, and 9% distant metastasis (Table 3). Regarding the behavior of cancer, 99.4% were malignant, and 0.6% were paired sites (Table 4).

The commonest histopathological finding was carcinoma (malignant and undifferentiated), followed by adenocarcinoma in 19.8% and papillary thyroid carcinoma in 10.5% (Table 5).

Table 1. Basic characteristics of the study group

Character

No%

Age

52.05±17.71

Sex

Males

Females

 

184 (52%)

170 (48%)

Nationality

Saudi

Non-Saudi

 

281 (79.4%)

73 (20.6%)

Marital status

Married

Single

Widowed

Unknown

 

171 (48.3%)

61 (17.2%)

02 (0.6)

120 (33.9%)

Residence

Tabuk City

Outside Tabuk

 

322 (90.97%)

32 (9.03%)

 

Table 2. Malignancy by site among patients in Tabuk City, Saudi Arabia

Character

No%

Breast

51 (14.4%)

Lymph nodes

Lymphoma

Other

64 (18.1%)

57 (16.1%)

07 (02%)

Colon

50 (14.1%)

Thyroid gland

43 (12.1%)

Ovary and uterus

13 (3.7%)

Nasopharynx

13 (3.7%)

Stomach

13 (3.7%)

Mouth and vocal cords

11 (3.1%)

Liver

11 (3.1%)

Lung

14 (3.9%)

Skin

06 (1.7%)

Pancreas

05 (1.4%)

Kidney

02 (0.7%)

Prostate

02 (0.7%)

Miscellaneous (rare)

54 (15.2%)

 

Table 3. The extent of malignancies among patients in Tabuk City, Saudi Arabia

Character

No%

Carcinoma in situ

217 (61.3 %)

Regional (direct spread)

06 (2%)

Regional lymph nodes

65 (18.4%)

Distant metastasis

32 (9%)

Unknown

33 (9.3%)

 

 

Table 4. The behavior of malignancies among patients in Tabuk City, Saudi Arabia

Character

No%

Malignant

352 (99.4 %)

Paired site

02 (0.6%)

 

Table 5. Histopathological Findings among Patients with Cancer in Tabuk City

Character

No%

Adenocarcinoma

70 (19.8%)

Squamous cell carcinoma

26 (7.3%)

Papillary carcinoma

37 (10.5%)

Carcinoma (malignant and undifferentiated)

104 (29.4%)

There is an increasing trend of cancer in Saudi Arabia. Breast cancer was the most common cancer in this study, followed by colon cancer; our findings are in a systematic review and meta-analysis published in Saudi Arabia and included thirty-nine studies.[10] The risk factors were various genetic polymorphism,[11-13] a lower folate uptake,[14] and vitamin D deficiency.[15] The trial conducted by Yousef et al. (2013) found an association between the incidence and invasiveness of breast cancer and low vitamin D levels. However, a single trial with a small sample size cannot conclude a cause and effect. Similar studies from Mexico and Iran [16] concluded the association between vitamin D deficiency and breast cancer. In this study, colon cancer constituted 14.1% of all types of cancer and was second most common; the current findings are in line with previous studies conducted in Saudi Arabia [17, 18] and found colon cancer second cancer after breast cancer. The authors explained their findings by the high rate of polymorphisms. However, Al-Ghafari et al. (2019) explained the high prevalence of breast cancer by vitamin D deficiency.[19] Aldiab et al. (2017), and Alqahtani et al. (2017) explained the high prevalence of prior ulcerative colitis and family history of Lynch syndrome. Thyroid cancer has increased substantially in the Kingdom of Saudi Arabia over the past three decades (fifteenfold in women and 22 times among men). Importantly, 2056 deaths occurred from thyroid cancer during the same period (the mortality increased three times in women and sixfold in men). In this study, thyroid cancer stands third among cancers in Tabuk City, in line with world trends [20] and contradicting previous observations.[10] The higher prevalence of thyroid cancer might be explained by the increasing detection and diagnosis.[21] Factors increasing mortality need future studies to reduce the mortality rate. A previous study conducted in Riyadh, Saudi Arabia [22] reported that thyroid cancer was the second most common cancer (10%); the current findings supported Hussain and colleagues' findings. However, the current findings were higher than studies conducted in the USA and reported a prevalence of 2.9%.[23] A study conducted in the southern region of Saudi Arabia [24] found that breast, colonic, and liver cancers are the most dominant in line with the current observation.

The geographic and spatial variation in cancer can be explained by radiation exposure,[25] lifestyles,[26] and iodine deficiency.[27] In the present study, the mean age group of the patients was 52.05±17.71 years, with an equal female/male ratio similar to Alshatwi et al. (2012).[11]

The study limitations

The study limitation was the retrospective nature, and the study was conducted at a single tertiary center.

Conclusion

The commonest malignancies in Tabuk City were breast, colon, and thyroid, respectively; carcinoma in situ was the commonest, followed by lymph node and distant metastasis. The histopathology varied between carcinoma, adenocarcinoma, and papillary carcinoma of the thyroid. Further prospective studies investigating cancer risk factors are needed.

Acknowledgments

None.

Conflict of interest

None.

Financial support

None.

Ethics statement

The records were approached confidentially with strict adherence to the Declaration of Helsinki. No patient identities were taken. The information collected was used only for this research. The ethical approval has been obtained from the ethical committee of the University of Tabuk, Saudi Arabia (ref. number, dated April 30, 2023).

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. doi:10.3322/caac.21660
  2. Arafa MA, Farhat KH. Why cancer incidence in Arab countries is much lower than in other parts of the world? J Egypt Natl Canc Ins. 2022;34:41. doi:10.1186/s43046-022-00142-3
  3. Alghamdi IG. Testicular cancer in Saudi Arabia between 2004 and 2017. Res Rep Urol. 2023;15:37-45. doi:10.2147/RRU.S393819
  4. Arafa MA, Rabah DM, Farhat K. Rising cancer rates in the Arab world: Now is the time for action. East Mediterr Health J. 2020;26(6):1-5.
  5. Alghamdi IG, Alghamdi MS. The incidence rate of liver cancer in Saudi Arabia: An observational descriptive epidemiological analysis of data from the Saudi cancer registry (2004-2014). Cancer Manag Res. 2020;12:1101-11. doi:10.2147/CMAR.S232600
  6. Alan D, Herbst BA, Reddy KR. Risk factors for hepatocellular carcinoma. Clin Liver Dis. 2012;1(6):180-3. doi:10.1002/cld.111
  7. Aljumah AA, Babatin M, Hashim A, Abaalkhail F, Bassil N, Safwat M, et al. Hepatitis B care pathway in Saudi Arabia: current situation, gaps, and actions. Saudi J Gastroenterol. 2019;25(2):73-80. doi:10.4103/sjg.SJG_421_18
  8. Al-Nozha MM, Al-Mazrou YY, Al-Maatouq MA, Arafah MR, Khalil MZ, Khan NB, et al. Obesity in Saudi Arabia. Saudi Med J. 2005;26(5):824-9.
  9. Saad MA. A review of the prevalence of obesity in Saudi Arabia. J Prevalence Obes Saudi Arabia. 2016;2:2-25.
  10. Alqahtani WS, Almufareh NA, Domiaty DM, Albasher G, Alduwish MA, Alkhalaf H, et al. Epidemiology of cancer in Saudi Arabia thru 2010-2019: A systematic review with constrained meta-analysis. AIMS Public Health. 2020;7(3):679-96. doi:10.3934/publichealth.2020053
  11. Alshatwi AA, Hasan TN, Shafi G, Alsaif MA, Al-Hazzani AA, Alsaif AA. A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population. Fundam Clin Pharmacol. 2012;26(3):438-43. doi:10.1111/j.1472-8206.2011.00939.x
  12. Al-Qasem A, Toulimat M, Tulbah A, Elkum N, Al-Tweigeri T, Aboussekhra A. The p53 codon 72 polymorphism is associated with risk and early onset of breast cancer among Saudi women. Oncol Lett. 2012;3(4):875-8. doi:10.3892/ol.2012.581
  13. Alanazi M, Pathan AA, Abduljaleel Z, Shaik JP, Alabdulkarim HA, Semlali A, et al. Association between PARP-1 V762A polymorphism and breast cancer susceptibility in Saudi population. PLoS One. 2013;8(12):e85541. doi:10.1371/journal.pone.0085541
  14. Alshatwi AA. Breast cancer risk, dietary intake, and methylenetetrahydrofolate reductase (MTHFR)single nucleotide polymorphisms. Food Chem Toxicol. 2010;48(7):1881-5. doi:10.1016/j.fct.2010.04.028
  15. Yousef FM, Jacobs ET, Kang PT, Hakim IA, Going S, Yousef JM, et al. Vitamin D status and breast cancer in Saudi Arabian women: A case-control study. Am J Clin Nutr. 2013;98(1):105-10. doi:10.3945/ajcn.112.054445
  16. Jamshidinaeini Y, Akbari ME, Abdollahi M, Ajami M, Davoodi SH. Vitamin D status and risk of breast cancer in Iranian women: A case-control study. J Am Coll Nutr. 2016;35(7):639-46. doi:10.1080/07315724.2015.1127786
  17. Al-Harithy RN, Al-Zahrani MH. The adiponectin gene, ADIPOQ, and genetic susceptibility to colon cancer. Oncol Lett. 2012;3(1):176-80. doi:10.3892/ol.2011.443
  18. Alharithy RN. Polymorphisms in RETN gene and susceptibility to colon cancer in Saudi patients. Ann Saudi Med. 2014;34(4):334-9. doi:10.5144/0256-4947.2014.334
  19. Al-Ghafari AB, Balamash KS, Al Doghaither HA. Relationship between Serum Vitamin D and Calcium Levels and Vitamin D Receptor Gene Polymorphisms in Colorectal Cancer. Biomed Res Int. 2019;2019:8571541. doi:10.1155/2019/8571541
  20. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133. doi:10.1089/thy.2015.0020
  21. Flemban AF, Kabrah S, Alahmadi H, Alqurashi RK, Turaes AS, Almaghrabi R, et al. Patterns of thyroid cancer mortality and incidence in Saudi Arabia: A 30-Year Study. Diagnostics (Basel). 2022;12(11):2716. doi:10.3390/diagnostics12112716
  22. Hussain F, Iqbal S, Mehmood A, Bazarbashi S, Elhassan T, Chaudhri N. Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2010. Hematol Oncol Stem Cell Ther. 2013;6(2):58-64. doi:10.1016/j.hemonc.2013.05.004
  23. Kim J, Gosnell JE, Roman SA. Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol. 2020;16(1):17-29. doi:10.1038/s41574-019-0263-x
  24. Alyami HS, Naser AY, Dahmash EZ, Alyami MH, Belali OM, Assiri AM, et al. Clinical and therapeutic characteristics of cancer patients in the southern region of Saudi Arabia: A cross-sectional study. Int J Environ Res Public Health. 2021;18(12):6654. doi:10.3390/ijerph18126654
  25. Thomas G. Radiation and thyroid cancer-an overview. Radiat Prot Dosimetry. 2018;182(1):53-7. doi:10.1093/rpd/ncy146
  26. Friedenreich CM, Ryder-Burbidge C, McNeil J. Physical activity, obesity and sedentary behavior in cancer etiology: Epidemiologic evidence and biologic mechanisms. Mol Oncol. 2021;15(3):790-800. doi:10.1002/1878-0261.12772
  27. Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3(4):286-95. doi:10.1016/S2213-8587(14)70225-6
© Clinical Cancer Investigation Journal
Online since 01 December, 2011
Creative Commons License 
ISSN Print: 2278-1668, Online: 2278-0513